Over time and with effort and determination, women in key leadership positions have proven that these positions are genderless for individuals with the correct set of abilities and knowledge.
Although equity and diversity are promoted in companies, barriers still exist related to obsolete prejudices that prevent progress in the equal development of women. Professional growth must be increased and promoted on equity, diversity, and integration, which directly impact and help develop good performance. We must continue to strengthen and incorporate the efforts so far as part of our daily organizational strategy.
In Mexico’s pharmaceutical industry, 46.5% of personnel are women,1 which could be considered a high percentage. However, only an average of 38% of women occupy key leadership positions in industry,2 including the pharmaceutical industry. Although it was a 3% increase from 2017 (35%) to 2020, it is a small increase. These statistics represent a challenge to achieve gender parity, not only in the pharmaceutical industry, but in all economic sec-tors.
To accelerate women’s participation, it is necessary to promote programs in companies for empowerment. To accomplish this, it is necessary to de-velop and promote different initiatives within industry and at a cultural level. Mexico is well-known for maintaining stereotypes and granting superiority to the masculine identity and the attitude that men “should have” over women. Although some think that this view has decreased, obstacles persist. The following would help address this issue:
Considering that women only occupy 38% of these key positions, their influence on decision-making at the management level is limited and the value that women’s leadership brings is not fully considered. The inclusion of women broadens the contribution of ideas to establish strategies for improvement and problem resolution.
Increasing women’s participation in executive leadership positions in the pharmaceutical industry can be managed from different points. Companies should create egalitarian policies to include and develop both men and women, in such a way that the same job opportunities are created in salaries, hiring, and representation in corresponding levels. These policies should involve general management, operational directors, and all company leaders so that the policies are created in an integral way.
A second goal is to implement programs for professional growth, such as mentoring and sponsorship programs. These can be created within companies, by associations related to the pharmaceutical industry, and within universities. Sponsor programs (such as the ISPE Mentor program) pair an experienced person with a new learner to strengthen the learner’s skills and abilities.
Professional growth programs directly involve and develop newer generations within the pharmaceutical industry and support the development of more egalitarian policies, which helps establish more women in executive leadership positions. These actions will reduce the discrepancy because when women fill leadership roles, they serve as examples of equity and promote inclusion and diversity.
Learn More About Women in Pharma®
Personalized medicine provides a treatment alternative that utilizes patients’ genetic material to produce therapeutics. According to Market Research Future, the US currently accounts for the largest share of the personalized medicine market, and it is expected to reach US $27.5 million by 2030.
ISPE has started 2024 with great momentum, having two technical conferences in the first quarter, the 2024 ISPE Facilities of the Future Conference in San Francisco, California and the 2024 ISPE...
ISPE GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition) outlines how to apply a risk-based approach to GxP computerized systems and is aligned with the FDA draft guidance “Computer...
